The prevalence of SMN gene deletion/duplication in spinal muscular atrophy families referred to neuro-genetic centers of Mashhad, Iran
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The prevalence of SMN gene deletion/duplication in spinal muscular atrophy families referred to neuro-genetic centers of Mashhad, Iran ; volume:25 ; number:1 ; day:31 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
The Egyptian journal of medical human genetics ; 25, Heft 1 (31.7.2024), 1-9, 12.2024
- Urheber
-
Shariati, Mohammad
Davoudi, Alireza
Boostani, Reza
Ashrafzadeh, Farah
Beiraghi Toosi, Mehran
Todarbary, Nafiseh
Akhondian, Javad
Hashemi, Narges
Sadr-Nabavi, Ariane
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-024-00551-0
- URN
-
urn:nbn:de:101:1-2410250838238.694449999510
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shariati, Mohammad
- Davoudi, Alireza
- Boostani, Reza
- Ashrafzadeh, Farah
- Beiraghi Toosi, Mehran
- Todarbary, Nafiseh
- Akhondian, Javad
- Hashemi, Narges
- Sadr-Nabavi, Ariane
- SpringerLink (Online service)
Ähnliche Objekte (12)
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
SMN
Understanding how SMN protein regulates the autophagy-lysosome pathway in spinal muscular atrophy
Posttranslational modifications of the Spinal Muscular Atrophy gene product SMN : Implications for therapy and pathophysiology
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes
Sonderdienst militärischer Nachrichten (SMN)
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy
Weekly reports referred
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
SMN
Understanding how SMN protein regulates the autophagy-lysosome pathway in spinal muscular atrophy
Posttranslational modifications of the Spinal Muscular Atrophy gene product SMN : Implications for therapy and pathophysiology
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes
Sonderdienst militärischer Nachrichten (SMN)
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy
Weekly reports referred
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
SMN
Understanding how SMN protein regulates the autophagy-lysosome pathway in spinal muscular atrophy
Posttranslational modifications of the Spinal Muscular Atrophy gene product SMN : Implications for therapy and pathophysiology
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes
Sonderdienst militärischer Nachrichten (SMN)
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy